RogCon, Inc.
1Patents
1Active
1Granted
39Portfolio score
Filing activity: Aug 20, 2019 → Aug 20, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11939582B2 | Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.